NYC

Physiomesh Hernia Mesh Lawyers

Ehicon Physiomesh Recall Lawyers

The Physiomesh is a Flexible Composite Hernia  Mesh  used in hernia repair surgery. The Physiomesh is made of a synthetic plastic-like material called polypropylene and is used as a patch to repair the hernia. It is the same exact material used in the Ethicon vaginal mesh that has caused problems in thousands of women.

Physiomesh Complications

 

  • Need for revision surgery due to mesh failure
  • Recurring hernia due to failure of the Physiomesh
  • Pain after surgery.
  • Recurring hernia in the first 6 months following surgery

Ethicon Physiomesh Lawyers Filing Physiomesh Lawsuits

If you have had a hernia repair surgery using the Ethicon Physiomesh and are experiencing complications contact our Physiomesh lawyers. Lawsuits are being filed against Ethicon Inc. for failure of their Physiomesh.

 

 

 

Bard IVC Filter Lawsuit Update | Cook IVC Filter Lawyer

The federal multi-district litigation panel for the Bard IVC Filters  has appointed a federal judge in Phoenix to oversee the C.R. Bard Inc. (NYSE: BCR) IVC filter consolidated lawsuits for all Bard Inferior Vena Cava filter lawsuits nationwide.

An  IVC filter was designed to capture  blood clots in patients who could not use  blood thinners. Our IVC Filter lawyers are filing defective IVC Filter lawsuits for people injured by a defective IVC Filter. Injuries include those from the fracturing of the filter and parts of the filter migrating and puncturing vital organs.  Faulty IVC filters puncture veins, fracture and migrate to other parts of the body causing injury and even death.

Why Are IVC Filter Lawsuits Being Filed?

IVC filter is problematic because   pieces can break off and thru-out the body and injure  parts of the body or get embedded in the organ tissue. These temporary IVC filters are supposed to be taken out within six months.  Very often the device is not removed in time to prevent complications.

IVC Filter Complications

Deep vein thrombosis
Difficulty in removing the filter
Movement of the entire filter or filter fragments to the heart or lungs
Fracture of the filter
Migration of the filter to another part of the body or vital organ
Perforation of the inferior vena cava
Tilting of the filter

If you or a loved one has been injured by a defective Bard or Cook Ivc Filter contact us to speak to an IVC Filter lawyer.

 

 

 

New York Personal Injury Lawyers, Accident and Injury Attorneys, NYC and Upstate New York

Do you have a New York Personal Injury lawsuit? Do you need an accident or injury  lawyer? Are you needing to file  a personal injury, negligence lawsuit. Auto accidents, Truck accidents,airport injury, tire blow outs, car seat malfunctions, airbag malfunction, seat belt malfunction, movie theater, fires, assaults, rape victims,  shopping mall, crossing the street, theme park injury, slip and fall, spine injury, head injury,  Bus accidents, subway injury,pedestrian accidents,18 wheel truck accidents, motorcycle accidents, cab driver accidents, injured children ans all accident, injury and wrongful death claims.

When you have been injured, it is critical that you are able to protect your rights and your best interests. You need the guidance of apersonal injury lawyers who have helped thousands of New York residents  through the same difficult type of circumstances.  We are your personal injury source. Here you will find the experience you need and office staff that is responsive to your pain a suffering.

New York city has some pretty dangerous highways. Here are the top 10:

1. Broadway (Manhattan), with 13 pedestrians killed from 2008-2010.
2. Broadway (The Bronx), 7 killed.
3. Kings Highway (Brooklyn), with 7 killed
4. Henry Hudson Parkway (Manhattan), 7 Killed
5. Atlantic Avenue (Brooklyn) 7 killed
6. Jamaica Avenue (Queens) 6 killed
7. Grand Concourse (Bronx), 6 killed
8. Brighton Beach Avenue (Brooklyn) 6
9. Amsterdam Avenue (Manhattan) 6
10. Union Turnpike (Queens) 6

Westchester and Rockland's commuter suburbs are home to some of the most treacherous and accident-prone roads in New York — with most crashes occurring during the evening rush hour, state records show. Finding a vehicle accident lawyer in Westchester is not difficult. But, if experience counts call our injury, accident helpline 24 hrs, 7 days..

New Jersey personal injury Lawyers and Accident Helpline lawyers are here to help you for NYC,  New York Injury lawyers.Albany, Binghamton,and the Bronx. Brooklyn, Buffalo, Catskills, Elmira, Finger Lakes,and Glens Falls lawyer, Hudson Valley, Long Island, Manhatten, Oneonta, Plattsburgh, Potsdam, Queens, Rochester, Staten Island, Syracuse, Twin Tiers, Utica, Watertown, Westchester, White Plains, Rockland County, Scenectady, Catskills, Utica,  Finger Lakes, Niagara Falls and the entire State of New York.

GranuFlo news Updates, Dialysis Medication Lawsuits Consolidation

 GranuFlo and Naturalyte heart attack form dialysis medication lawyers are filing  lawsuits for cardiac injury and death from GranuFlo and Naturalyte.

There was a  class 1 recall of GranuFlo last year  due to cardiac injury during or just after dialysis treatment. NaturaLyte is a liquid acid concentrate and GranuFlo is a dry acid concentrate. Both products contain sodium acetate that converts to bicarbonate at higher then expected rates leading to immediate cardiac arrest in many dialysis patients and cardiac injury bin others.
At year's end in 2012,a  Motion to Consolidate the cases into multidistrict litigation (MDL) for all federal lawsuit was filed. A request  has been filed with the U.S. Judicial Panel on Multidistrict Litigation asking that all Naturalyte and GranuFlo lawsuits filed in U.S. District Courts throughout the country be consolidated for pretrial proceedings in the District of Massachusetts.
Early in 2013,  Fresenius said in court papers that it agreed that consolidation of the NaturaLyte and Granuflo litigation was appropriate and supported the transfer of the cases to the District of Massachusetts
 On January 3, several Plaintiffs with pending lawsuits have objected to centralizing the cases in Massachusetts, indicating that the litigation should be consolidated in the southeast, because of the number of cases filed in that region. Their choices are the Southern District of Mississippi and the Northern District of Alabama have been requested. Many Florida retired seniors are dialysis patents and have been injured or killed sue to a cardiac episode from GranuFlo or Naturalyte.

Dialysis Injury Help Center, GranuFlo Naturalyte Helpline

Lawyers for GranuFlo and Naturalyte are filing lawsuits for dialysis injury from Granuflo and Naturalyte. Fresenius Medical Care’s dialysis product GranuFlo is  a medication  that  dialysis centers   use to treat acute and chronic kidney failure.
 

Your kidneys clean the blood of waste  products  and help maintain the body’s pH level. When they fail, the body’s pH level become more acidic than is should be.  Kidney failure is treated with chemicals that help the body convert ph level. These substances convert  into the alkaline substance bicarbonate, which neutralizes some of the acid buildup in the blood stream.
GranuFlo  and Naturalyte have had issues with this conversion and have shown instances of immediate  heart attacks as a side effect. GranuFlo contains more bicarbonate than other dialysates.

The June 2012 New York Times article describes Fresenius’s knowledge of these risks  of granuFlo and Naturalyte and the product’s high bicarbonate level. According to the article, Fresenius sent a memo to its clinics warning that the higher bicarbonate levels in GranuFlo had caused 941 heart attacks in the company’s own clinics in 2010, leading the company’s researchers to estimate that GranuFlo increases a patient’s risk of heart attack by six times. Fresenius did not send the memo to GranuFlo-using clinics that the company didn’t own, however, until March 29, 2012, when the FDA consequently began investigating Fresenius for possible violations of federal regulations, the Times reports.

Currently GranuFlo and Naturalyte lawyers are accepting claims against Fresenius for immediate hear attack  form their GranuFlo and Naturalyte products. A number of dialysis patients may have already been injured by GranuFlo. If  GranuFlo diaysis medication caused a sudden heart attack or cardiac arrest, hemodialysis cardiac arrest or cardiopulmonary arrest, stroke, or arrhythmia speak to a GranuFlo lawyer now by calling the GranuFlo legal team of free legal Shield. We seek justice for seniors.

GranuFlo Lawyers, NaturaLyte Lawsuits

 

Fresenius Medical is the manufacturer of  GranuFlo and NaturaLyte acid concentrate. These are drugs used in  dialysis treatment. There has been a recall of these dialysis drugs and  lawsuits are being filed.

Injury and death has resulted from these drugs:

  •  GranuFlo cardiovascular death,
  •  GranuFlo sudden cardiac death,
  •  GranuFlo cardiopulmonary arrest,
  •  GranuFlo heart attack,
  •  GranuFlo catastrophic cardiovascular injuries

 

Fresenius manufactures GranuFlo and NaturaLyte used in dialysis. These drugs cause alkalosis, a condition associated with an increase in cardiovascular fatalities.

 

The FDA received complaints describing alkali dosing errors that occurred during hemodialysis using dialysate concentrates containing acetic acid and acetate. When metabolized, these potential sources of alkali can contribute to elevated bicarbonate levels in patients undergoing hemodialysis.

 

This can contribute to metabolic alkalosis, which is a significant risk factor associated with :

 

Low blood pressure

Cardiopulmonary arrest

Cardiac arrhythmia

Sudden heart attack

Stroke

Hemodialysis cardiopulmonary arrest

 

A study which was conducted between January and December of 2010 found that patients with pre-dialysis bicarbonate levels greater than 28mEq/L were 4.7 times more likely to suffer a cardiac arrest. The study also discovered that patients with pre-dialysis potassium lower than 4 mEq/L had a 6.3 times higher risk of cardiac arrest.

 

In May 2012 the FDA notified health care providers to consider the presence and quantity of acetate, citrate, and/or acetic acid in dialysate concentrates when determining the patients’ dialysate prescription.

There is a GranuFlo and NaturaLyte Class 1 Recall

 

Serial numbers for recalled Naturalyte Liquid Acid Concentrate range from:

 

08-0231-4, 08-1001-0, 08-1201-8, 08-1231-3, 08-1251-1, 08-1301-4, 08-2201-5, 08-2231-2, 08-2251-0, 08-2301-3,08-2351-8, 08-3201-4, 08-3231-1, 08-3251-9, 08-3301-2, 08-4123-1, 08-4223-7, 08-4225-1, 08-4230- 2, 08-4231-0, 08-4323-5, 08-4325-1, 13-1251-1, 13-2201-5, 13-2231-2, 13-2251-0, 13-3231-1, 13-3251-9, 13-4123-1, 13-4220-1, 13-4225-1, 13-4325-

 

Serial numbers for recalled Naturalyte GranuFlo (powder) Acid Concentrate range from:

 

OFD1201-3B, OFD1251-3B, OFD2123-3B, OFD2201-38, OFD2220-3B, OFD2223-3B, OFD2225-3B, OFD2231-3 B, OFD2251-3B, OFD2301-3B, OFD2323-3 B, OFD2325-3B, OFD3201-3B, OFD3231-3B, OFD3251-3B, OFD3301-3B

GranuFlo & NaturaLyte is one of the most widely prescribed dry acid products used for dialysis  at Fresenius'  clinics, as well as other hemodialysis centers that purchase their dialysis supplies from Fresenius.  It is estimated that 125,000 patients in non-Fresenius clinics are treated with GranuFlo.

Dilaysis Patient Alert

If you, a loved one or someone you care for has been injured by these products contact us for a GranuFlo and NaturaLyte lawsuit.

Bladder Sling Lawyers, Vaginal Mesh Lawsuits

The bladder mesh is a vaginal mesh product primarily used for urinary incontinence. This mesh sling has caused severe complications and bladder mesh lawyers are filing lawsuits. Many women with a bladder mesh do not realize they are eligible to file a vaginal mesh lawsuit.

What is a Bladder Sling?

Urethral sling or bladder sling  is used  to treat urinary incontinence by placing a sling around the urethra to lift it back into a normal position and to exert pressure on the urethra to aid urine retention. The sling is attached to the abdominal wall. A bladder sling is a mesh device and is part of the vaginal mesh litigation. The complications of a failed bladder sling is increased incontinence or trouble voiding. Many women have needed to self catherize.

 Bladder Sling Complications?

According to the July 2011 FDA news release, the most common complications associated with surgical mesh bladder slings is erosion thru the vaginal wall or into the bladder, pain during sexual intercourse, bleeding, infection, perforation of various pelvic organs (bladder, colon, vaginal walls), and urinary incontinence or problems voiding as well as; neuromuscular problems, emotional problems, mesh contraction/shrinkage, and even a reoccurrence of POP and/or SUI.

Bladder sling lawsuits are being filed on a contingency fee basis against the mnaufacturers of the bladder sling:

        Bard Avaulta Support System
        AMS Elevate Prolapse Repair System
        AMS Apogee Vault Suspension System
        AMS Perigee System
        AMS Monarc Sling System
        AMS Sparc Sling System
        Ethicon Gynecare Gynemesh
        Ethicon Gynecare Prolene Soft Mesh
        Ethicon Gynecare Prolift Pelvic Floor Repair System
        Ethicon Gynecare TVT Transvaginal Sling
        Boston Scientific Pinnacle Pelvic Floor Repair Kit
        Boston Scientific Uphold Vaginal Support System
        UGYTEX Dual Knit Mesh
        Coviden IVS Tunneler Sling

Contact us today.

Stryker Hip Replacement Lawyers, Stryker Hip Replacement Helpline

Adding to the Zimmer and DePuy metal on metal hip replacement Stryker has recalled it's latest metal component hip replacement implant.  Stryker has voluntarily recalled the  Rejuvenate metal component hip replacement implant and ABG II modular- neck stems
Stryker has voluntarily  stopped  market distribution of these hip replacements due to  increased risk of injury. The hip replacement implants have been shown to fret or corrode, harming body tissue and causing pain and  swelling. Other injuries include:

  •     Severe inflammatory reactions
  •     Pain in the groin
  •     metal toxicity ort poisoning
  •     high metal levels in the blood
  •     need for additional surgery
  •     Breakdown of muscles, tendons and other soft tissues in and around the hip joint
  •     Loss of surrounding bone
  •     Loss of mobility

While other types of hip implants such as those made by Johnson & Johnson and DePuy Orthopaedics Inc. involve a metal ball rubbing against a metal socket, the Stryker Rejuvenate products involve a metal neck inside a metal stem. The Stryker Hip replacement Helpline and  hip replacement lawyers are reaching out to all victims of the failed device for a potential multi district litigation.

The products have metal components and although they are not metal on metal run the same risks of chromium and cobalt toxicity poisoning. If you have been injured you are advised to contact your doctor immediately and contact the Stryker Hip Replacement Helpline for a Stryker lawyer

Hurricane Claims Lawyers, Storm Claims Lawyers

If you have a claim for a Hurricane You need an Experienced  Insurance Bad Faith lawyer Fihting for your rights. Our team of Insurance Claim lawyers are experienced in Florida windstorms, Hurricanes, and tornado damgae claims. You can count on us for Hurricane and windstorm as well as flood claims.Windstorms, Hurricanes Florida Hurricane Insurance Claim Attorneys and Florida Lawyers, helpling with Hurricane Damage claims and  Windstorm Damage Claims.

Windstorms, hurricanes and tornadoes can create massive destruction. When wind damage occurs, it can open the door to complicated ambiguities with insurance coverage during the adjustment process. In the aftermath of a disaster,  you will need help with

  •     Protecting your property.
  •     Getting your business or home back to normal.
  •     Securing adequate financial recovery.
     

As a home owner , business owners and property owners we are faced  with threat of property damage each year from windstorms, tropical storms and hurricanes. Hurricanes in 2004 and 2005 caused tremendous damage to residential and commercial properties in Florida. Property owners often faced insurance companies determined to deny claims or minimize claim payments. While most of these hurricane insurance claims have since been resolved, there is no doubt many victims of future storms will have problems with their insurers..

If you are an individual, business, condo association or homeowner’s association in the state of Florida and have suffered a property loss due to a windstorm or hurricane, we encourage you to contact the experienced insurance law attorneys at Tyler & Hamilton, P.A. To contact our Jacksonville law office, call 904.398.9999, or in Florida call us toll-free at 1.800.344.1122.
Lawyers Protecting Your Rights in Wind Damage Claims in Miami, Ft Lauderdale,Orlando, Jacksonville, Tampa, Ft Myers, Winter haven, ocala Sarasota, West Palm Beach and Throughout Florida. Expanded coverage for storm damage victims in NYC and New Jersey. We know storms. Your best bet is an experinced hurrican damage lawyer.

When a windstorm or hurricane causes your home or business property to sustain water damage, structural damage or other property damage, you have a right to receive the full benefits under your insurance policy. This could include cost of repairs, temporary/alternative residence costs, storage costs, transportation costs and other additional costs incurred due to the windstorm damage.

insurance companies have their own goals. They want to prevent you from receiving the full benefit of your homeowner’s, commercial or commercial, residential insurance policy.
Our Hurricane, Tornado, wind, storm and flood Lawyers will help you Receive  aggressive Representation for your hurricane and Tornado Claims,

The states with most Tornadeos are : Texas, Massachusetts, Oklahoma, Missisppi

States with most hurricanes

 

  • Texas,
  • Louisiana,
  • Mississippi,
  • Alabama ,
  • Florida,, 
  • Georgia,
  • South Carolina,
  • North Carolina,

History of Breast Implants, Breast Implant Lawyers, Dow Corning breast Implant Claims

Breast Implant lawyers are still to this date helpling women resolve their Dow Corning Breast Implant Claims of the Breast Implant Class action of years ago. In light of this it is interesting to look at the history of Breast Implants, FDA has approved a New silicone breast Implant and despite the horrors women are still going for that well endowed look.

 

1940s
Japanese prostitutes have their breasts injected with substances such as paraffin, sponges and non-medical grade silicone to enlarge their breasts, believing that American servicemen favor women with large breasts.

1960s
The first silicone breast implants are developed by two plastic surgeons from Texas: Frank Gerow and Thomas Cronin.

1962
Timmie Jean Lindsey becomes the first woman to receive silicone breast implants.

1976
The Food and Drug Administration enacts the Medical Devices Amendment to the Federal Food, Drug and Cosmetic Act. FDA now has the authority to review and approve the safety and effectiveness data of new medical devices. But since silicone breast implants have been on the market for almost 15 years, they are "grandfathered." Manufacturers of the implants, when called to do so by the FDA, will be required to provide safety and effectiveness data.

1977
Richard Mithoff, a Houston attorney, wins the first lawsuit for a Cleveland woman who claims that her ruptured implants and subsequent operations had caused pain and suffering. She receives a $170,000 settlement from Dow Corning. Case receives little publicity.

1980s
Ralph Nader's Public Citizen Health Research Group, Washington, D.C. sends out warning signals that silicone breast implants cause cancer.

January 1982
FDA proposes to classify silicone breast implants into a Class III category which would require manufacturers to prove their safety in order to keep them on the market.

1984
Stern vs Dow Corning, San Francisco. Case wins on many internal Dow Corning documents that had been discovered in a Dow storage area by attorney Dan Bolton . Maria Stern's systemic autoimmune disease is found by a jury to be caused by her silicone breast implants. Bolton introduces the silicone-induced problems for the first time in court, with "experts" that theorize the silicone-immune system connection. After a monthlong trial, the jury awards Maria Stern $211,000 in compensatory damages and $1.5 million in punitive damages. The evidence is sealed by a court order.

June 1988
Six years after the 1982 proposal, FDA classifies the implants into Class III. Premarket Approval Applications from silicone breast implant manufacturers are due by July 1991. The PMA's must prove affirmatively, with valid scientific data evaluated by the FDA, that their devices are safe and effective. After the PMA's are submitted by the manufacturers, the FDA has 180 days to evaluate the safety data.

December 1990
Program on the dangers of silicone breast implants airs on "Face to Face with Connie Chung."

December 1990
Congressional hearing headed by Representative Ted Weiss deals with the safety of silicone breast implants. This hearing also discusses the fact that not all the information that the manufacturers have are available for public scrutiny due to a court order from the Stern verdict.

July 1991
Dow Corning releases 329 studies to FDA.

July 1991
Toole vs Baxter, Alabama. Jury decides against Baxter/Heyer-Shulte and awards the largest settlement so far, $5.4 million, to Brenda Toole. Toole, who shows only preliminary symptoms of systemic autoimmune problems, nevertheless had silicone in her lymphatic system according to plaintiffs' witnesses and thus an increased risk of developing an autoimmune disease.

September 1991
FDA concludes that the silicone breast implant manufacturers' safety data does not prove the devices are safe–or harmful. Manufacturers are told to submit further data.

November 1991
The FDA brings together its General and Plastic Surgery Devices Panel to review all of the safety data from the manufacturers' PMA's. The purpose of the panel is to advise FDA as to what they could tell the public about the safety and effectiveness of the silicone breast implants based on the PMA's. The panel is composed of a broad range of experts, including representatives from the fields of plastic surgery, oncology, epidemiology, internal medicine, immunology, radiology, pathology, gynecology, toxicology, sociology, biomaterials and psychology, as well as industry and consumer groups. The panel hearing rejects the data from Dow Corning, Mentor, McGhan, and Bioplasty, concluding there is not sufficient data about the risks and benefits of the devices. The panel recommends the devices stay on the market temporarily and with limited access. The need for more safety data is stressed.

December 1991
Hopkins vs Dow Corning, San Francisco. The largest award yet, $7.3 million, is given to Mariann Hopkins whose mixed connective- tissue disease is linked to her ruptured silicone breast implants. The lawyer for the case, Dan Bolton, wins the suit with the help of internal memos and studies from the Stern lawsuit,     in addition to new studies he recently obtained from Dow. Mr. Bolton gives several of the internal documents to the FDA which has never seen the documents before.

December 1991
To date, 137 individual lawsuits have been filed against Dow Corning.

January 1992
FDA Commissioner, David Kessler, calls for a voluntary moratorium on the distribution or implantation of silicone breast implants until the FDA and the advisory panel have an opportunity to consider newly available information. The manufacturers agree.

February 1992
The class action lawsuit is filed in Cincinnati by Stan Chesley. The hope is to compensate women at a faster rate than filing individual lawsuits.

February 1992
Dow Corning CEO, Lawrence Reed, is replaced by Keith McKennon.

February 1992
The General and Plastic Surgery Devices Panel reconvenes to review the new information regarding the safety of silicone breast implants. The panel recommends that the further use of implants be limited for reconstruction only and that women receiving the implants participate in scientific protocols and that epidemiologic studies be conducted to assess the risk of autoimmune disease. The panel concludes that no causal link has been established between autoimmune disease and silicone breast implants.

February 1992
Many of the Dow Corning internal memos are released to the public.

March 1992
Dow Corning leaves the silicone breast implant business as do Bristol-Myers Squibb and Bioplasty. McGhan and Mentor will still manufacture breast implants. Dow sets up a fund for further research into the safety of breast implants.

April 1992
Dr. Kessler lifts the moratorium on silicone breast implants. The only women allowed to receive implant surgery are those undergoing breast reconstruction. All of the implant recipients must become part of a scientific protocol.

May 1992
First woman gets implants under new rules.

December 1992    
Johnson vs Bristol-Myers Squibb, Houston. Pamela Jean Johnson wins $25 million, $5 million actual damages and $20 million punitive damages in a case argued by Texas attorney John O'Quinn. A jury finds Ms. Johnson's ruptured silicone implants were linked to her mixed connective tissue disease, auto-immune responses, chronic fatigue, muscle pain, joint pain, headaches, and dizziness. Expert witnesses and lawyers admit her symptoms amount to "a bad flu."

December 1992
To date 3,558 individual lawsuits have been filed against Dow Corning.

June 1993    
Dick Hazleton becomes CEO of Dow Corning.

December 1993
By year's end 12,359 individual lawsuits have been filed against Dow Corning.

March 1994
A Houston jury awards three women a total of $27.9 million against 3M, $15 million in punitive, $12 million in compensatory damages for illness. The lawyer arguing the case against 3M is John O'Quinn. The three women suffered from either atypical lupus, neurological impairment, and a "silicone induced" autoimmune problem.

March 1994
The class action suit is finalized by manufacturers with Dow Corning being the largest contributor. The other contributors include Baxter, Bristol-Myers Squibb/MEC, 3M. It is the largest class action settlement in history. Manufacturers claim there is no scientific evidence linking silicone breast implants with autoimmune diseases. There are set monetary amounts that will be awarded to women with specific medical conditions. No requirements are needed to prove implants are the cause of their ailments. Women will be allowed to drop out of the settlement. Companies can also opt out if too few women register claims.

April 1994
Preliminary approval to class action by Judge Pointer. Clears the way for women to start applying for claims in the settlement.

June 1994
The Mayo Clinic epidemiologic study is published in the New England Journal of Medicine, which finds no increased risk of connective-tissue disease and other disorders that were studied in women with silicone implants.

September 1994
Final approval of class action/global settlement from Judge Pointer.

December 1994
By this date 19,092 individual lawsuits have been filed against Dow Corning.

1995
The American College of Rheumatology issues a statement saying the evidence is "compelling" that implants did not cause systemic disease.

February 1995
Gladys Laas vs Dow Corning.

May 1995
Dow Corning files for Chapter 11 bankruptcy. Dow is facing 20,000 lawsuits, some with multiple plaintiffs and about 410,000 potential claims that have been filed in the global settlement. The bankruptcy essentially halts all litigation.

June 1995
About 440,000 women have registered in the global settlement. About 70,000 can be immediately compensated.

June 1995
The Harvard Nurses Epidemiologic Study is published in the New England Journal of Medicine. This finds no increased risk of connective-tissue disease or certain signs and symptoms     of connective-tissue disease in women with silicone implants.

October 1995
Mahlum vs Dow Chemical, Reno. This is the first case where Dow Chemical, the parent company of Dow Corning, is the sole defendant. Charlotte Mahlum is awarded $3.9 million in compensatory damages and $10 million in punitive damages. About 13,000 breast implant lawsuits are pending against Dow Chemical.

November 1995
New global settlement is devised minus Dow Corning. Bristol-Myers Squibb, Baxter and 3M are the participants. The monetary awards are less than the previous settlement.

December 1995
By now 15 individual lawsuits against Dow Corning have gone to trial involving some 19 plaintiffs. Of these, Dow Corning have had 8 trial "wins" and 6 trial "losses," with one split decision.

December 1995    
By now more than 20 (non-case report) studies and abstracts have come out in the U.S. and internationally, all failing to support a causal relationship between silicone implants and a variety of auto-immune related illnesses.

April 1996
Two Federal judges in New York appoint an impartial, expert panel to review the scientific issues involved in breast implant lawsuits. This rare move will influence judges throughout the country.

September 1996
The California Court of Appeal upholds a decision dismissing Dow Chemical and Dow Corning from 1,800 breast-implant lawsuits.

December 1996
Oregon Federal Judge Robert E. Jones, after input from a panel of impartial scientists, rules that plaintiffs' lawyers cannot present evidence that silicone implants caused disease because it is scientifically invalid. He dismisses 70 claims, shocking the litigation community.
Sam C. Pointer, the Alabama judge overseeing all federal implant cases, appoints his own panel of scientific experts who are not connected to implant litigation.

January 1997
The American Academy of Neurology reviews existing silicone implant studies and reports that "existing research shows no link between silicone breast implants and neurological disorders."

March 1997
A judge in Michigan rules that the Dow Chemical Company is not liable for the medical problems of hundreds of women in the state. Thus far, some state appellate courts have upheld Dow Chemical's liability and others have not.

August 1997
The New York Times reports that implant manufacturers have been winning 80% of cases against them. Nevertheless, a state jury in the first class-action suit finds that Dow Chemical (which owns half of Dow Corning) knowingly deceived women by hiding safety information about the silicone in their implants.

September 1997
The Journal of the National Cancer Institute publishes a review of scores of medical studies that concludes breast implants do not cause breast cancer. The researchers described the evidence for linking implants to any other disease as "borderline."

December 1997
The first class-action lawsuit in an implant case is reduced to its original eight claimants when a Louisiana judge decides the 1,800 women have cases too dissimilar to group into one lawsuit.

April 1998
Two large Scandinavian studies fail to show that silicone implants are linked to neurological disease.

July 1998
Plaintiffs agree to Dow Corning's offer of $3.2 billion to settle tens of thousands of claims of injury from silicone breast implants. The agreement will let the plaintiffs receive money within a year and also enable Dow Corning to emerge from bankruptcy proceedings.
After being asked by the British minister of health to review the safety of silicone implants, a seven-member panel of scientists report no convincing evidence that they cause disease. (The U.K. has never removed silicone implants from the market.)

November 1998
Dow Corning files for bankruptcy reorganization, which includes the $3.2 billion previously agreed-to settlement and offers claimants several payout options. Those who want to cash-out immediately and not file a disease claim will be paid $2,000. This figure can also be combined with $5,000 for implant removal surgery and $20,000 for a ruptured implant. Those who have already filed a disease claim will receive between $10,000 and $250,000 plus any compensation claimed for removal or ruptures.

December 1998
After two years and $800,000, a panel of four independent experts appointed by Judge Sam C. Pointer, overseer of implant lawsuits in the Federal courts, concludes that scientific evidence so far has failed to show that silicone breast implants cause disease.
Nevada Supreme Court upholds a compensatory damage award of $41 million against Dow Chemical to Charlotte Mahlum for her multiple-sclerosis-like symptoms. Dow Chemical was earlier found liable for helping Dow Corning conceal evidence about the harmful effects of silicone. The court, however, overturns a $10 million punitive award.

 Breast Implant Class action, Breast Implant lawyers January 1999
A jury in a Washington Federal court awards $10 million in compensatory damages against Bristol-Myers Squibb Co. to an attorney who claimed her implants caused scleroderma.

Spring 1999 Silicone-gel-filled Breast implants
Silicone-gel-filled implants remain off the market in the U.S. pending manufacturer safety studies. They are available only to women who have had or will have breast surgery for a medical condition or have other complications from existing implants, and only if they agree to be part of a scientific protocol, or study. The latest status of silicone breast implants can be found at the FDA website.

June 1999
The Institute of Medicine releases a 400-page report prepared by an independent committee of 13 scientists. They conclude that although silicone breast implants may be responsible for localized problems such as hardening or scarring of breast tissue, implants do not cause any major diseases such as lupus or rheumatoid arthritis. The Institute of Medicine is part of the National Academy of Sciences, the nation's most prestigious scientific organization. Congress had asked the Institute to set up the committee. The committee did not conduct any original research; they examined past research and other materials, and conducted public hearings to hear all sides of the issue.